Showing results (131-140 of 233) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profilingJeffrey Haessler, John D Shaughnessy, Fenghuang Zhan, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 31, 2013
Patterns of central nervous system involvement in relapsed and refractory multiple myelomaAl-ola Abdallah, Shebli Atrash, Zainab Shahid, et al.
Journal of Hematology & Oncology|August 9, 2020
The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myelomaSamrat Roy Choudhury, Cody Ashby, Ruslana Tytarenko, et al.
Haematologica|January 11, 2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseMateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
Clinical Hematology International|September 30, 2024
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple MyelomaTanvi H Patel, Ramya Bachu, Trilok Shrivastava, et al.
Blood Cancer Journal|August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q SyndromeJeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
Blood|May 22, 2008
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalitiesBart Barlogie, Mauricio Pineda-Roman, Frits van Rhee, et al.
Blood Advances|November 22, 2021
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myelomaMeera Mohan, Samantha Kendrick, Aniko Szabo, et al.
The Journal of Clinical Investigation|October 26, 2023
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesionsFumou Sun, Yan Cheng, Jin-Ran Chen, et al.
Haematologica|May 30, 2015
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)Rashid Khan, Madhav Dhodapkar, Adam Rosenthal, et al.
Pageof 24